Ganguly Kingsuk, Van Helmond Noud, Friedman Adam, Ahmad Rabeel, Bowen Frank, Shersher David D, Mitrev Ludmil V
Department of Anesthesiology, Cooper University Hospital, Camden, USA.
Department of Anesthesiology, Cooper Medical School of Rowan University, Camden, USA.
Cureus. 2024 Jun 10;16(6):e62085. doi: 10.7759/cureus.62085. eCollection 2024 Jun.
Introduction For peripheral nerve blocks, using either the liposomal formulation of bupivacaine or plain bupivacaine with epinephrine and dexamethasone as an adjuvant has been shown to improve postoperative pain scores. In a single-blinded, randomized controlled study of patients undergoing robotic-assisted thoracoscopic surgery, we determined if bupivacaine with epinephrine and dexamethasone was noninferior to liposomal bupivacaine mixed with plain bupivacaine when administered intraoperatively as an intercostal nerve block (INB). Methods A total of 34 patients undergoing robotic-assisted thoracoscopic surgery were randomized to receive one of two injectate mixtures during their intraoperative INB. Group LB was administered 266 mg of 13.3 mg/mL liposomal bupivacaine with 24 mL of 0.5% plain bupivacaine, while Group BD was given 42 mL of 0.5% bupivacaine with epinephrine and 8 mg of dexamethasone. The primary outcomes were mean postoperative numerical pain ratings and mean postoperative opioid analgesic requirements. Secondary outcomes included adjuvant pain medication consumption, hospital length of stay, and total opioid use in oral morphine equivalents. Results Group LB exhibited no significant difference in pain scores (p = 0.437) and opioid analgesic requirement (p = 0.095) within the 72-hour postoperative period when compared to Group BD. The median total postoperative opioid requirement was 90 mg in Group LB, compared to 45 mg in Group BD. There were no significant differences in the use of postoperative adjuvant pain medications (gabapentin, p = 0.833; acetaminophen, p = 0.190; ketorolac, p = 0.699). Hospital length of stay did not differ between the groups. Conclusions INBs with the addition of dexamethasone as an adjuvant to 0.5% bupivacaine with epinephrine provided noninferior postoperative analgesia compared to liposomal bupivacaine mixed with plain 0.5% bupivacaine.
引言 对于周围神经阻滞,已证明使用布比卡因脂质体剂型或使用普通布比卡因加肾上腺素和地塞米松作为佐剂均可改善术后疼痛评分。在一项针对接受机器人辅助胸腔镜手术患者的单盲随机对照研究中,我们确定术中作为肋间神经阻滞(INB)给药时,含肾上腺素和地塞米松的布比卡因是否不劣于脂质体布比卡因与普通布比卡因的混合剂。方法 共有34例接受机器人辅助胸腔镜手术的患者在术中INB时被随机分配接受两种注射混合剂中的一种。LB组接受266 mg的13.3 mg/mL布比卡因脂质体与24 mL的0.5%普通布比卡因,而BD组接受42 mL含肾上腺素的0.5%布比卡因和8 mg地塞米松。主要结局为术后平均数字疼痛评分和术后平均阿片类镇痛药需求量。次要结局包括辅助性镇痛药的消耗量、住院时间以及以口服吗啡当量计算的阿片类药物总用量。结果 与BD组相比,LB组在术后72小时内的疼痛评分(p = 0.437)和阿片类镇痛药需求量(p = 0.095)无显著差异。LB组术后阿片类药物总需求量中位数为90 mg,而BD组为45 mg。术后辅助性镇痛药(加巴喷丁,p = 0.833;对乙酰氨基酚,p = 0.190;酮咯酸,p = 0.699)的使用无显著差异。两组住院时间无差异。结论 对于INB,在含肾上腺素的0.5%布比卡因中添加地塞米松作为佐剂,与脂质体布比卡因与0.5%普通布比卡因混合剂相比,术后镇痛效果不劣。